alizapride
Sign in to saveAlizapride (Litican, Plitican, Superan, Vergentan) is a dopamine antagonist with prokinetic and antiemetic effects used in the treatment of nausea and vomiting, including postoperative nausea and vomiting. It is structurally related to metoclopramide and other benzamides.
Research
115 papers- Therapeutic Use of Cannabis and Cannabinoids: A Review.JAMA · 2026
- Alizapride in prevention of postoperative nausea and vomiting.The Netherlands journal of surgery · 1988
- Alizapride and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic gynaecological surgery: A double-blind, randomised, placebo-controlled noninferiority study.European journal of anaesthesiology · 2016
- [Pharmacodynamics of alizapride (author's transl)].La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris · 1982
- Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial.Cancer chemotherapy and pharmacology · 1988
via PubMed
Article
3 sectionsContents
- Mechanism
- Synthesis
- References
Alizapride (Litican, Plitican, Superan, Vergentan) is a dopamine antagonist with prokinetic and antiemetic effects used in the treatment of nausea and vomiting, including postoperative nausea and vomiting. It is structurally related to metoclopramide and other benzamides.
== Mechanism == Alizapride blocks D2 dopamine receptors in the vomiting center.